Literature DB >> 21086062

Duodenal-jejunal bypass surgery does not increase skeletal muscle insulin signal transduction or glucose disposal in Goto-Kakizaki type 2 diabetic rats.

Timothy P Gavin1, Ruben C Sloan, Eric Z Lukosius, Melissa A Reed, John R Pender, Van Boghossian, Jacqueline J Carter, Robert D McKernie, Kushal Parikh, J William Price, Edward B Tapscott, Walter J Pories, G Lynis Dohm.   

Abstract

BACKGROUND: Duodenal-jejunal bypass (DJB) has been shown to reverse type 2 diabetes (T2DM) in Goto-Kakizaki (GK) rats, a rodent model of non-obese T2DM. Skeletal muscle insulin resistance is a hallmark decrement in T2DM. The aim of the current work was to investigate the effects of DJB on skeletal muscle insulin signal transduction and glucose disposal. It was hypothesized that DJB would increase skeletal muscle insulin signal transduction and glucose disposal in GK rats.
METHODS: DJB was performed in GK rats. Sham operations were performed in GK and nondiabetic Wistar-Kyoto (WKY) rats. At 2 weeks post-DJB, oral glucose tolerance (OGTT) was measured. At 3 weeks post-DJB, insulin-induced signal transduction and glucose disposal were measured in skeletal muscle.
RESULTS: In GK rats and compared to sham operation, DJB did not (1) improve fasting glucose or insulin, (2) improve OGTT, or (3) increase skeletal muscle insulin signal transduction or glucose disposal. Interestingly, skeletal muscle glucose disposal was similar between WKY-Sham, GK-Sham, and GK-DJB.
CONCLUSIONS: Bypassing of the proximal small intestine does not increase skeletal muscle glucose disposal. The lack of skeletal muscle insulin resistance in GK rats questions whether this animal model is adequate to investigate the etiology and treatments for T2DM. Additionally, bypassing of the foregut may lead to different findings in other animal models of T2DM as well as in T2DM patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21086062      PMCID: PMC3832996          DOI: 10.1007/s11695-010-0304-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  27 in total

1.  Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region.

Authors:  S Dadke; J Kusari; J Chernoff
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

2.  The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass.

Authors:  W J Pories; J F Caro; E G Flickinger; H D Meelheim; M S Swanson
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

3.  The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization.

Authors:  R A DeFronzo; E Jacot; E Jequier; E Maeder; J Wahren; J P Felber
Journal:  Diabetes       Date:  1981-12       Impact factor: 9.461

4.  Effect of exercise on synthesis and degradation of muscle protein.

Authors:  G L Dohm; G J Kasperek; E B Tapscott; G R Beecher
Journal:  Biochem J       Date:  1980-04-15       Impact factor: 3.857

5.  Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance.

Authors:  Joseph T Brozinick; Brian R Roberts; G Lynis Dohm
Journal:  Diabetes       Date:  2003-04       Impact factor: 9.461

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

Review 8.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

9.  Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

Authors:  Bruno Geloneze; Sylka R Geloneze; Carla Fiori; Christiane Stabe; Marcos A Tambascia; Elinton A Chaim; Brenno D Astiarraga; Jose Carlos Pareja
Journal:  Obes Surg       Date:  2009-05-12       Impact factor: 4.129

10.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

Authors:  R A DeFronzo; E Ferrannini; D C Simonson
Journal:  Metabolism       Date:  1989-04       Impact factor: 8.694

View more
  14 in total

1.  Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.

Authors:  Samuel Klein; Elisa Fabbrini; Bruce W Patterson; Kenneth S Polonsky; Carlos A Schiavon; Jose L Correa; Joao E Salles; Bernardo L Wajchenberg; Ricardo Cohen
Journal:  Obesity (Silver Spring)       Date:  2012-01-19       Impact factor: 5.002

2.  Roux-en Y gastric bypass is superior to duodeno-jejunal bypass in improving glycaemic control in Zucker diabetic fatty rats.

Authors:  Florian Seyfried; Marco Bueter; Kerstin Spliethoff; Alexander D Miras; Kathrin Abegg; Thomas A Lutz; Carel W le Roux
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

3.  Duodenojejunal Bypass Plus Sleeve Gastrectomy Reduces Infiltration of Macrophages and Secretion of TNF-α in the Visceral White Adipose Tissue of Goto-Kakizaki Rats.

Authors:  Hao Yu; Zhigao Song; Hongbin Zhang; Kehong Zheng; Junfang Zhan; Qing Luo; Jingbo Sun; Li Liang; Xiaojiang Dai; Liangping Wu
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

4.  Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition.

Authors:  Zhibo Yan; Weijie Chen; Shaozhuang Liu; Guangyong Zhang; Dong Sun; Sanyuan Hu
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

5.  Duodeno-jejunal bypass restores β-cell hypersecretion and islet hypertrophy in western diet obese rats.

Authors:  Mariana Carla Mendes; Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Camila Lubaczeuski; Ana Flavia Justino Fêo; Rodrigo Vargas; Everardo Magalhães Carneiro; Antonio Carlos Boschero; Allan Cezar Faria Araujo; Sandra Lucinei Balbo
Journal:  Endocrine       Date:  2018-03-19       Impact factor: 3.633

6.  Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.

Authors:  Dong Sun; Kexin Wang; Zhibo Yan; Guangyong Zhang; Shaozhuang Liu; Fengjun Liu; Chunxiao Hu; Sanyuan Hu
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

7.  The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats.

Authors:  Eivind Grong; Ingerid Brænne Arbo; Ole Kristian Forstrønen Thu; Esther Kuhry; Bård Kulseng; Ronald Mårvik
Journal:  Surg Endosc       Date:  2014-08-09       Impact factor: 4.584

Review 8.  Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m(2): A Surgeon's Perspective.

Authors:  Ricardo Cohen; Pedro Paulo Caravatto; Tarissa Petry
Journal:  Obes Surg       Date:  2013-06       Impact factor: 4.129

9.  Effects of duodeno-jejunal bypass on glucose metabolism in obese rats with type 2 diabetes.

Authors:  Hirofumi Imoto; Chikashi Shibata; Fumie Ikezawa; Daisuke Kikuchi; Soutoku Someya; Koh Miura; Takeshi Naitoh; Michiaki Unno
Journal:  Surg Today       Date:  2013-06-20       Impact factor: 2.549

10.  Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats.

Authors:  Jian Jiao; Eun Ju Bae; Gautam Bandyopadhyay; Jason Oliver; Chaitra Marathe; Michael Chen; Jer-Yuan Hsu; Yu Chen; Hui Tian; Jerrold M Olefsky; Maziyar Saberi
Journal:  Diabetes       Date:  2012-12-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.